Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Testosterone II Assay Improved for Female Samples

By LabMedica International staff writers
Posted on 29 Mar 2010
A new, improved testosterone II assay is more accurate for female samples.

The new automated testosterone assay reduces cross reactivity to dehydroepiandrosterone sulphate (DHEAS) and susceptibility to matrix effect with female samples. More...
It ensures reliable results, helping clinicians to improve diagnoses of andrenogenital syndrome, polycystic ovary (Stein-Leventhal syndrome), ovarian tumor, adrenal tumor, adrenal hyperplasia, or ovarian insufficiency.

A Roche (Burgess Hill, UK) product, the Elecsys testosterone II assay delivers enhanced accuracy against the gold standard ID-gas chromatograph/mass spectrography (GC/MS) methods for female samples in the range of 0.025-1.5 ng/mL. The improved performance of the assay is due to a new high affinity testosterone monoclonal antibody. The antibody enables optimized recovery of testosterone and ensures excellent precision, especially at low concentration levels.

The short turnaround time of the Elecsys testosterone II assay (18 minutes) and small sample volume required (20 µl) improves workflow and allows complete endocrinology panel testing from one patient sample. The assay can be used on Roche's modular analyzers-- cobas 8000, cobas 6000, cobas 4000, and Elecsys 2010 platforms.

First generation assays frequently over-estimate testosterone in the female matrix. This effect is variable and cannot be predicted for any given sample. The Elecsys testosterone II assay was developed as part of Roche's commitment to improvement and in response to customer feedback about high recovery with female samples, which did not fit the clinical picture.

Roche offers a large endocrinology menu, which includes fully automated DHEAS, sex hormone-binding globulin (SHBG), anti-thyroid-stimulating hormone-receptor antibody (TSHR) and adrenocorticotropin hormone (ACTH) assays.

Related Links:

Roche



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.